0001042167-21-000049.txt : 20210621
0001042167-21-000049.hdr.sgml : 20210621
20210621125137
ACCESSION NUMBER: 0001042167-21-000049
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210616
FILED AS OF DATE: 20210621
DATE AS OF CHANGE: 20210621
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FISCH HARRY
CENTRAL INDEX KEY: 0001688984
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-13602
FILM NUMBER: 211029264
MAIL ADDRESS:
STREET 1: 515 N. STATE STREET, SUITE 2225
STREET 2: C/O THE FEMALE HEALTH COMPANY
CITY: CHICAGO
STATE: IL
ZIP: 60654
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERU INC.
CENTRAL INDEX KEY: 0000863894
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 391144397
STATE OF INCORPORATION: WI
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 48 NW 25TH STREET
STREET 2: SUITE 102
CITY: MIAMI
STATE: FL
ZIP: 33127
BUSINESS PHONE: 3125959123
MAIL ADDRESS:
STREET 1: 48 NW 25TH STREET
STREET 2: SUITE 102
CITY: MIAMI
STATE: FL
ZIP: 33127
FORMER COMPANY:
FORMER CONFORMED NAME: FEMALE HEALTH CO
DATE OF NAME CHANGE: 19960205
FORMER COMPANY:
FORMER CONFORMED NAME: WISCONSIN PHARMACAL COMPANY INC
DATE OF NAME CHANGE: 19920703
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2021-06-16
0
0000863894
VERU INC.
VERU
0001688984
FISCH HARRY
48 NW 25TH STREET
SUITE 102
MIAMI
FL
33127
1
0
1
0
Common Stock
2021-06-16
4
S
0
100000
8.353
D
764025
D
Common Stock
7239096
I
Footnote 3
The price reported above is the weighted average transaction price. The range of prices for such transaction is $8.23 to $8.48. Upon request by the Commission staff, the reporting person will provide full information regarding the number of shares sold at each separate price.
Includes 541,144 shares held jointly by the reporting person and his spouse.
The shares are held by K&H Fisch Family Partners, LLC, of which the reporting person is the sole manager. The reporting person disclaims beneficial ownership of these shares, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of these shares for purposes of Section 16 or any other purpose.
/s/ Phil M. Greenberg, via Power of Attorney
2021-06-18